000 02657nam a2200373 i 4500
001 CR9781009129169
003 UkCbUP
005 20240301142636.0
006 m|||||o||d||||||||
007 cr||||||||||||
008 210701s2022||||enk o ||1 0|eng|d
020 _a9781009129169 (ebook)
020 _z9781009123396 (hardback)
020 _z9781009125765 (paperback)
040 _aUkCbUP
_beng
_erda
_cUkCbUP
050 0 0 _aRA638
_b.S263 2022
082 0 0 _a615.3/72
_223/eng/20220211
100 1 _aSantos Rutschman, Ana,
_d1983-
_eauthor.
245 1 0 _aVaccines as technology :
_binnovation, barriers, and the public health /
_cAna Santos Rutschman.
264 1 _aCambridge, United Kingdom ; New York, NY :
_bCambridge University Press,
_c2022.
300 _a1 online resource (xi, 191 pages) :
_bdigital, PDF file(s).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aTitle from publisher's bibliographic system (viewed on 07 Apr 2022).
505 0 _aVaccines as instruments of public health -- The vaccine development ecosystem -- Vaccine development under proprietary paradigms -- Access to vaccine technology -- Aligning vaccine innovation with public health needs -- Vaccines of the future : present and emerging challenges -- Conclusion: Broader implications for global public health.
520 _aThe COVID-19 pandemic served as a powerful wake-up call, highlighting our collective need for the effective development and equitable distribution of new vaccines, in addition to widespread administration of existing ones. The current models of production and allocation of vaccines against emerging pathogens, which rely on predominantly market-driven mechanisms, are largely at odds with public health needs. This book is the first to explore the entire arc of vaccine development and distribution, from the decisions about allocation of vaccine R&D money to allocation and administration of vaccines resulting from the R&D process. It explains key concepts and problems in vaccine regulation, intellectual property, technology transfer, and international relations, making complex material accessible to a non-specialist audience. Analyzing the impact of COVID-19, the book also covers several other vaccine races, as well as future directions in vaccine development and allocation.
650 0 _aVaccines
_xResearch
_xGovernment policy.
650 0 _aVaccination
_xLaw and legislation.
650 0 _aPharmaceutical policy.
650 0 _aMedical policy.
776 0 8 _iPrint version:
_z9781009123396
856 4 0 _uhttps://doi.org/10.1017/9781009129169
999 _c9323
_d9323